Role of intestinal Bifidobacterium pseudolongum in dietary fructo-oligosaccharide inhibition of 2,4-dinitrofluorobenzene-induced contact hypersensitivity in mice

British Journal of Nutrition

Volumn 103, Issue 4, 2010, Pages 539-548

  Sasajima, Naho ^a   Ogasawara, Toru ^a   Takemura, Naoki ^a   Fujiwara, Reiko ^a   Watanabe, Jun ^a   Sonoyama, Kei ^a  

^a HOKKAIDO UNIVERSITY   (Japan)

Author keywords

Bifidobacteria; Contact hypersensitivity; Mice; Prebiotics

Indexed keywords

1 FLUORO 2,4 DINITROBENZENE; FRUCTOSE OLIGOSACCHARIDE; GAMMA INTERFERON; HAPTEN; IMMUNOGLOBULIN G1 ANTIBODY; IMMUNOGLOBULIN G2A ANTIBODY; INTERLEUKIN 10; IMMUNOGLOBULIN G; OLIGOSACCHARIDE; PREBIOTIC AGENT; PROBIOTIC AGENT; RNA 16S;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BACTERIUM ISOLATION; BIFIDOBACTERIUM; BIFIDOBACTERIUM PSEUDOLONGUM; CERVICAL LYMPH NODE; CONTACT ALLERGY; CONTROLLED STUDY; CYTOKINE PRODUCTION; DIET SUPPLEMENTATION; FECES ANALYSIS; FECES MICROFLORA; FEMALE; GENE SEQUENCE; MOUSE; NONHUMAN; SWELLING; ANIMAL; BAGG ALBINO MOUSE; BIOSYNTHESIS; BLOOD; CARBOHYDRATE DIET; CONTACT DERMATITIS; DIET; DIET THERAPY; EAR; EDEMA; FECES; INTESTINE; LYMPH NODE; METABOLISM; MICROBIOLOGY;

BIFIDOBACTERIUM PSEUDOLONGUM; MUS;

ANIMALS; BIFIDOBACTERIUM; DERMATITIS, CONTACT; DIET; DIETARY CARBOHYDRATES; DIETARY SUPPLEMENTS; DINITROFLUOROBENZENE; EAR; EDEMA; FECES; FEMALE; HAPTENS; IMMUNOGLOBULIN G; INTERFERON-GAMMA; INTERLEUKIN-10; INTESTINES; LYMPH NODES; MICE; MICE, INBRED BALB C; OLIGOSACCHARIDES; PREBIOTICS; PROBIOTICS; RNA, RIBOSOMAL, 16S;

EID: 77649207218     PISSN: 00071145     EISSN: 14752662     Source Type: Journal    
DOI: 10.1017/S0007114509992145     Document Type: Article

References (44)

1. Wills-Karp M, Santeliz J & Karp CL (2001) The germless theory of allergic disease: revisiting the hygiene hypothesis. Nat Rev Immunol 1, 69-75.
2. Macpherson AJ & Harris NL (2004) Interactions between commensal intestinal bacteria and the immune system. Nat Rev Immunol 4, 478-485.
3. Björkstén B (2007) Effects of intestinal microflora and the environment on the development of asthma and allergy. Springer Semin Immunopathol 25, 257-270.
4. Kalliomaki M, Salminen S, Arvilommi H, et al. (2001) Probio-tics in primary prevention of atopic disease: a randomised placebo-controlled trial. Lancet 357, 1076-1079.
5. Kalliomaki M, Salminen S, Poussa T, et al. (2003) Probiotics and prevention of atopic disease: 4-year follow-up of a randomised placebo-controlled trial. Lancet 361, 1869-1871.
6. Isolauri E, Arvola T, Sutas Y, et al. (2000) Probiotics in the management of atopic eczema. Clin Exp Allergy 30, 1604-1610.
7. Taylor A, Dunstan J & Prescott SL (2007) Probiotic supplementation for the first 6 months of life fails to reduce the risk of atopic dermatitis and increases the risk of allergen sensitisation in high risk children: a randomised controlled trial. J Allergy Clin Immunol 119, 184-191.
8. Brouwer ML, Wolt-Plompen SA, Dubois AE, et al. (2006) No effects of probiotics on atopic dermatitis in infancy: a randomized placebo-controlled trial. Clin Exp Allergy 36, 899-906.
9. Folster-Holst R, Muller F, Schnopp N, et al. (2006) Prospective, randomized controlled trial on Lactobacillus rhamnosus in infants with moderate to severe atopic dermatitis. Br J Dermatol 155, 1256-1261.
10. Prescott SL & Björkstén B (2007) Probiotics for the prevention or treatment of allergic diseases. J Allergy Clin Immunol 120, 255-262.
11. Gibson GR, Beatty ER, Wang X, et al. (1995) Selective stimulation of bifidobacteria in the human colon by oligofructose and inulin. Gastroenterology 108, 975-982.
12. Blaut M (2002) Relationship of prebiotics and food to intestinal microflora. Eur J Nutr 41, 11-16.
13. Sartor RB (2004) Therapeutic manipulation of the enteric microflora in inflammatory bowel diseases: antibiotics, probio-tics, and prebiotics. Gastroenterology 126, 620-633.
14. Macfarlane S, Macfarlane GT & Cummings JH (2006) Review Article: prebiotics in the gastrointestinal tract. Aliment Pharmacol Ther 24, 701-714.
15. Moro G, Arslanoglu S, Stahl B, et al. (2006) A mixture of pre-biotic oligosaccharides reduces the incidence of atopic dermatitis during the first six months of age. Arch Dis Child 91, 814-819.
16. Arslanoglu S, Moro GE, Schmitt J, et al. (2008) Early dietary intervention with a mixture of prebiotic oligosaccharides reduces the incidence of allergic manifestations and infections during the first two years of life. J Nutr 138, 1091-1095.
17. Watanabe H, Sonoyama K, Watanabe J, et al. (2004) Reduction of allergic airway eosinophilia by dietary raffinose in Brown Norway rats. Br J Nutr 92, 247-255.
18. Sonoyama K, Watanabe H, Watanabe J, et al. (2005) Allergic airway eosinophilia is suppressed in ovalbumin-sensitized Brown Norway rats fed raffinose and a-linked galactooligosac-charide. J Nutr 135, 538-543.
19. Fujitani S, Ueno K, Kamiya T, et al. (2007) Increased number of CCR4-positive cells in the duodenum of ovalbumin-induced food allergy model Nc/jic mice and antiallergic activity of fruc-tooligosaccharides. Allergol Int 56, 131-138.
20. Vos AP, van Esch BC, Stahl B, et al. (2007) Dietary supplementation with specific oligosaccharide mixtures decreases parameters of allergic asthma in mice. Int Immunopharmacol 7, 1582-1587.
21. Olmos A, Giner RM, Recio MC, et al. (2007) Effects of plant alkylphenols on cytokine production, tyrosine nitration and inflammatory damage in the efferent phase of contact hypersen-sitivity. Br J Pharmacol 152, 366-373.
22. Krasteva M, Kehren J, Ducluzeau MT, et al. (1999) Contact dermatitis I. Pathophysiology of contact sensitivity. Eur J Dermatol 9, 65-77.
23. \+T cells in contact hypersensitivity and allergic contact dermatitis. Eur J Dermatol 14, 131-138.
24. Watanabe J, Sasajima N, Aramaki A, et al. (2008) Consumption of fructo-oligosaccharide reduces 2,4-dinitrofluorobenzene-induced contact hypersensitivity in mice. Br J Nutr 100, 339-346.
25. Reeves PG, Nielsen FH & Fahey GC Jr (1993) AIN-93 purified diets for laboratory rodents: final report of the American Institute of Nutrition ad hoc writing committee on the reformulation of the AIN-76A rodent diet. J Nutr 123, 1939-1951.
26. Silvi S, Rumney CJ & Rowland IR (1996) An assessment of three selective media for bifidobacteria in faeces. J Appl Bacteriol 81, 561-564.
27. Ben-Amor K, Heilig H, Smidt H, et al. (2005) Genetic diversity of viable, injured, and dead fecal bacteria assessed by fluorescence-activated cell sorting and 16S rRNA gene analysis. Appl Environ Microbiol 71, 4679-4689.
28. Kwon HS, Yang EH, Lee SH, et al. (2005) Rapid identification of potentially probiotic Bifidobacterium species by multiplex PCR using species-specific primers based on the region extending from 16S rRNA through 23S rRNA. FEMS Microbiol Lett 250, 55-62.
29. Gurtler V & Stanisich VA (1996) New approaches to typing and identification of bacteria using the 16S-23S rDNA spacer region. Microbiology 142, 3-16.
30. Nagai H, Matsuo A, Hiyama H, et al. (1997) Immunoglobulin E production in mice by means of contact sensitization with a simple chemical, hapten. J Allergy Clin Immunol 100, S39-S44.
31. Zoetendal EG, Akkermans AD & De Vos WM (1998) Temperature gradient gel electrophoresis analysis of 16S rRNA from human fecal samples reveals stable and host-specific communities of active bacteria. Appl Environ Microbiol 64, 3854-3859.
32. Wasaki J, Rothe A, Kania A, et al. (2005) Root exudation, phosphorus acquisition, and microbial diversity in the rhizo-sphere of white lupine as affected by phosphorus supply and atmospheric carbon dioxide concentration. J Environ Qual 34, 2157-2166.
33. Rinttilä T, Kassinen A, Malinen E, et al. (2004) Development of an extensive set of 16S rDNA-targeted primers for quantification of pathogenic and indigenous bacteria in faecal samples by real-time PCR. J Appl Microbiol 97, 1166-1177.
34. \+T cell-mediated skin inflammation. Eur J Immunol 34, 2520-2528.
35. Abbas AK, Murphy KM & Sher A (1996) Functional diversity of helper T lymphocytes. Nature 383, 787-793.
36. \+ type 1 cytotoxic T cells both play a crucial role in the full development of contact hypersensitivity. J Immunol 165, 6783-6790.
37. Kimber I & Dearman RJ (2002) Allergic contact dermatitis: the cellular effectors. Contact Dermatitis 46, 1-5.
38. Toebak MJ, Gibbs S, Bruynzeel DP, et al. (2009) Dendritic cells: biology of the skin. Contact Dermatitis 60, 2-20.
39. de Waard R, Garssen J, Snel J, et al. (2001) Enhanced antigen-specific delayed type hypersensitivity and immunoglobulin G2b responses after oral administration of viable Lactobacillus casei YIT9029 in Wistar and Brown Norway rats. Clin Diagn Lab Immunol 8, 762-767.
40. de Waard R, Claassen E, Bokken GC, et al. (2003) Enhanced immunological memory responses to Listeria monocytogenes in rodents, as measured by delayed-type hypersensitivity (DTH), adoptive transfer of DTH, and protective immunity, following Lactobacillus casei Shirota ingestion. Clin Diagn Lab Immunol 10, 59-65.
41. Vos AP, Haarman M, Buco A, et al. (2006) A specific prebiotic oligosaccharide mixture stimulates delayed-type hypersensitiv-ity in a murine influenza vaccination model. Int Imuuno-pharmacol 6, 1277-1286.
42. Oboki K, Ohno T, Saito H, et al. (2008) Th17 and allergy. Allergol Int 57, 121-134.
43. Nakae S, Komiyama Y, Nambu A, et al. (2002) Antigen-specific T cell sensitization is impaired in IL-17-deficient mice, causing suppression of allergic cellular and humoral responses. Immunity 17, 375-387.
44. \+ IL-17-producing T cells are important in effector functions for the elicitation of contact hypersensitivity responses. J Immunol 177, 6852-6858.